REGN
Valuation Healthcare · Biotechnology Data as of 2026-03-31P/E Ratio · Metrics
P/E Ratio
28.61
PEG Ratio
0.51
Dividend Yield
-
Gross Margin
81.43%
Net Margin
20.17%
Revenue CAGR 3Y
4.47%
ROE
9.26%
ROA
7.12%
Buyback Yield
-0.19%
Current Ratio
3.57
Magic Earn Yield
4.07%
Altman Z-Score
7.07
Fair Value River
Score
Valuation 51
Profitability 42
Growth 15
Health 100
Yield 0